CANRENOATE POTASSIUM
Potassium canrenoate is a prodrug of canrenone, acting as a potassium‑sparing diuretic and aldosterone antagonist. It treats edema and heart failure. Side effects include hyperkalemia, GI upset, and dizziness.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of action
Potassium canrenoate is a water-soluble prodrug of canrenone, a mineralocorticoid receptor antagonist. It blocks aldosterone binding in the distal nephron, reducing sodium reabsorption and potassium excretion. This leads to natriuresis, mild diuresis and reduced fibrosis signalling.
Benefits and advantages
Used in renal-physiology research, mineralocorticoid-receptor studies, heart-failure modelling, aldosterone-pathway analysis and comparisons between canrenone derivatives.
Side effects and risks
Risks include hyperkalaemia, renal dysfunction, endocrine disturbances (gynecomastia), hypotension and GI upset. Handle with careful electrolyte-monitoring protocols.
Datasheet
| Molecular Formula | C22H29KO4 |
|---|---|
| Molecular Weight | 396.6 g/mol |
| CAS Number | 102731 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | potassium canrenoate; 2181-04-6; CANRENOATE POTASSIUM; Kanrenol; Soldactone |
| IUPAC/Chemical Name | potassium 3-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoate |
| InChl Key | JTZQCHFUGHIPDF-RYVBEKKQSA-M |
| InChl Code | InChI=1S/C22H30O4.K/c1-20-9-5-15(23)13-14(20)3-4-16-17(20)6-10-21(2)18(16)7-11-22(21,26)12-8-19(24)25;/h3-4,13,16-18,26H,5-12H2,1-2H3,(H,24,25);/q;+1/p-1/t16-,17+,18+,20+,21+,22-;/m1./s1 |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.
